Mesenchymal stromal cells: Misconceptions and evolving concepts

Cytotherapy

Volumn 15, Issue 2, 2013, Pages 140-145

  Phinney, Donald G ^a   Senseb́e, Luc ^b,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c CNRS   (France)

Author keywords

Adult stem cells; Marrow stromal cells; Mesenchymal stem cells; Multipotent mesenchymal stromal cells

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ADAPALENE; ALPHA1 INTEGRIN; BETA1 INTEGRIN; CD146 ANTIGEN; CD39 ANTIGEN; CD51 ANTIGEN; ENDOGLIN; FETAL ANTIGEN; HERMES ANTIGEN; NESTIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; THY 1 ANTIGEN; VASCULAR CELL ADHESION MOLECULE 1;

ADIPOSE TISSUE; APOPTOSIS; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CELL IMMORTALIZATION; CELL POPULATION; CLINICAL TRIAL (TOPIC); ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HISTOCOMPATIBILITY COMPLEX; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MESENCHYMAL STROMA CELL; MULTIPLE MYELOMA; MULTIPLE SCLEROSIS; NEURAL CREST; NONHUMAN; OSTEOBLAST; PERICYTE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 84875458995     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2012.11.005     Document Type: Review

References (50)

1. Phinney DG. Marrow stem. In: Polak J, Mantalaris S, Harding S, editors. Advances in tissue engineering. London: Imperial College Press; 2008. p. 95-122.
2. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309-13.
3. Koc O, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000;18:307-16.
4. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267-74.
5. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279-95.
6. Gronthos S, Graves SE, Ohta S, Simmons PJ. The STRO1 fraction of adult human bone marrow contains the osteogenic precursors. Blood. 1994;84:4164-73.
7. Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Min Res. 2003;18:694-704.
8. Brachvogel B, Moch H, Pausch F, Schlotzer-Schrehardt U, Hofmann C, von der Mark K, et al. Perivascular cells expressing annexin A5 define a novel mesenchymal stem celllike population with the capacity to differentiate into multiple mesenchymal lineages. Development. 2005;132:2657-68.
9. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3:301-13.
10. Covas DT, Panepucci RA, Fontes AM, Silva WA Jr, Orellana MD, Freitas MC, et al. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146 perivascular cells and fibroblasts. Expt Hematol. 2008;36:642-54.
11. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119:2204-13.
12. Batouli S, Miura M, Brahim J, Tsutsui TW, Fisher LW, Gronthos S, et al. Comparison of stem-cell-mediated osteogenesis and dentinogenesis. J Dent Res. 2003;2:976-81.
13. Dellavalle A, Maroli G, Covarello D, Azzoni E, Innocenzi A, Perani L, et al. Pericytes resident inpostnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. Nat Comm. 2011;2:499.
14. Takashima Y, Era T, Nakao K, Kondo S, Kasuga M, Smith AG, et al. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell. 2007;129:1377-88.
15. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, et al. Mesenchymal and hematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466:829-34.
16. Battula VL, Evans KW, Hollier BG, Shi Y, Marini FC, Ayyanan A, et al. Epithelial-mesenchymal transition-derived cells exhibit multi-lineage differentiation potential similar to mesenchymal stem cells. Stem Cells. 2010;28:1435-45.
17. Isenmann S, Arthur A, Zannettino AC, Turner JL, Shi S, Glackin CA, et al. TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment. Stem Cells. 2009;27:2457-68.
18. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair - current views. Stem Cells. 2007; 25:2896-902.
19. Etchevers HC, Vincent C, Le Douarin NM, Couly GF. The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development. 2001;128:1059-68.
20. Muller SM, Stolt CC, Terszowski G, Blum C, Amagai T, Kessaris N, et al. Neural crest origin of perivascular mesenchyme in the adult thymus. J Immunol. 2008;180:5344-51.
21. Brown CB, Baldwin HS. Neural crest contribution to the cardiovascular system. Adv Exp Med Biol. 2006;589:134-54.
22. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol. 2002;30:783-91.
23. Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007;131:324-36.
24. Charbord P, Livne E, Gross G, Haupl T, Neves NM, Marie P, et al. Human bone marrow mesenchymal stem cells: a systematic reappraisal via the genostem experience. Stem Cell Rev. 2011;7:32-42.
25. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-7.
26. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol. 1999;107:275-81.
27. Larson BL, Ylöstalo J, Prockop DJ. Human multipotent stromal cells undergosharp transition from division to development in culture. Stem Cells. 2008;26:193-201.
28. N-emeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15:42-9.
29. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5: 54-63.
30. Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, de Zwart P, et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen 1. Haematologica. 2009;94:173-84.
31. Phinney DG. Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy. Cell Cycle. 2007;6:2884-9.
32. Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, Leboff MS, et al. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell. 2008;7:335-43.
33. Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am. 1997; 79:1699-709.
34. Wagner W, Ho AD. Mesenchymal stem cell preparations - comparing apples and oranges. Stem Cell Rev. 2007;3:239-48.
35. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci. 2000;113: 1161-6.
36. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells. 2010;28:788-98.
37. Russell KC, Lacey MR, Gilliam JK, Tucker HA, Phinney DG, O'Connor KC. Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency. Biotechnol Bioeng. 2011;108: 2716-26.
38. Sengers BG, Dawson JI, Oreffo ROC. Characterization of human bone marrow stromal cell heterogeneity for skeletal regeneration strategies using a two-stage colony assay and computational modeling. Bone. 2010;46:496-503.
39. Ylöstalo J, Bazhanov N, Prockop DJ. Reversible commitment to differentiation by human multipotent stromal cells in singlecell- derived colonies. Exp Hematol. 2008;36:1390-402.
40. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for production of human mesenchymal stem cells. Stem Cells. 2006;24:42-7.
41. Phinney DG. Isolation of mesenchymal stem cells from murine bone marrow by immunodepletion. Methods Mol Biol. 2008;449:171-86.
42. Prowse KR, Greider CW. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci U S A. 1995;92:4818-22.
43. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells. 2007;25:371-9.
44. Boregowda S, Krishnappa V, Chambers J, LoGrasso PV, Lai W-T, Ortiz LA, et al. Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53 dependent mechanism: implications for procurement methods that rely on long-term culture expansion of bone marrow. Stem Cells. 2012;30: 975-87.
45. Gunn WG, Conley A, Deininger L, Olson SD, Prockop DJ, Gregory CA. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells. 2006;24: 986-91.
46. Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD Jr. Dkk1- induced inhibitionof Wnt signaling in osteoblast differentiation is an underlying mechanism of boneloss in multiple myeloma. Bone. 2008;42:669-80.
47. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood. 2005;106:1755-61.
48. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2:141-50.
49. François M, Romieu-Mourez R, Li M, Galipeau J. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther. 2012;20:187-95.
50. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579-86.